P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION

• V. Montefusco,
• A.M. Cafro,
• G. Margiotta Casaluci,
• F. Patriarca,
• R. Mina,
• M. D’Agostino,
• A. Capra,
• C. Priola,
• B. Dalla Palma,
• R. Rizzi,
• A. Genua,
• M.T. Petrucci,
• L. Paris,
• A. Belotti,
• M. Cavo,
• C. Conticello,
• C. Carlo-Stella,
• M Boccadoro

Affiliations

V. Montefusco

1 European Myeloma Network (EMN) Italy, Milan, Italy

A.M. Cafro

1 European Myeloma Network (EMN) Italy, Milan, Italy

G. Margiotta Casaluci

2 Pavia, Italy

F. Patriarca

3 Udine, Italy

R. Mina

4 Torino, Italy

M. D’Agostino

4 Torino, Italy

A. Capra

4 Torino, Italy

C. Priola

4 Torino, Italy

B. Dalla Palma

5 Parma, Italy

R. Rizzi

6 Bari, Italy

A. Genua

7 Terni, Italy

M.T. Petrucci

8 Roma, Italy

L. Paris

9 Bergamo, Italy

A. Belotti

10 Brescia, Italy

M. Cavo

11 Bologna, Italy

C. Conticello

12 Catania, Italy

C. Carlo-Stella

13 Rozzano, Italy

M Boccadoro

4 Torino, Italy